LON:GWP - GW Pharmaceuticals Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started GBX 716.60 -18.40 (-2.50 %) (As of 07/17/2018 05:49 AM ET)Previous CloseGBX 716.60Today's RangeGBX 716.60 - GBX 716.6052-Week RangeGBX 211 - GBX 950Volume135,500 shsAverage Volume956,721 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A Company ProfileAnalyst RatingsInsider TradesHeadlinesChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email GW Pharmaceuticals plc is a biopharmaceutical company focused on developing and commercializing therapeutics from its cannabinoid product platform in a range of disease areas. The Company's lead cannabinoid product candidate is Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol (CBD). The Company offers Sativex (nabiximols), which is indicated for the treatment of spasticity due to multiple sclerosis (MS). The Company operates through three segments: Commercial, Sativex Research and Development, and Pipeline Research and Development. The Commercial segment distributes and sells the Company's commercial products. The Sativex Research and Development segment seeks to maximize the potential of Sativex through the development of new indications. The Pipeline Research and Development segment seeks to develop cannabinoid medications other than Sativex across a range of therapeutic areas using its cannabinoid technology platform. Receive GWP News and Ratings via Email Sign-up to receive the latest news and ratings for GWP and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange LON Industry N/A Sub-IndustryN/A SectorN/A SymbolLON:GWP CUSIPN/A Webwww.gwpharm.com Phone+44-1223-266800 Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / CashN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net Margins-819.10% Return on Equity-51.18% Return on Assets-44.49% Miscellaneous EmployeesN/A Outstanding Shares302,090,000Market Cap£0.00 GW Pharmaceuticals (LON:GWP) Frequently Asked Questions What is GW Pharmaceuticals' stock symbol? GW Pharmaceuticals trades on the London Stock Exchange (LON) under the ticker symbol "GWP." What is the consensus analysts' recommendation for GW Pharmaceuticals? 0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for GW Pharmaceuticals in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A." Who are GW Pharmaceuticals' key executives? GW Pharmaceuticals' management team includes the folowing people: Geoffrey W. Guy, Executive Chairman of the BoardJustin Gover, Chief Executive Officer, DirectorAdam David George, Chief Financial Officer, Company Secretary, DirectorChristopher John Tovey, Chief Operating Officer, Executive DirectorJulian S. Gangolli, Executive DirectorJames Julian Noble, Non-Executive Deputy Chairman of the Board, Senior Independent DirectorCabot Brown, Non-Executive Independent DirectorThomas Gerard Lynch, Non-Executive Independent DirectorCatherine J. Mackey Ph.D., Non-Executive Independent DirectorAlicia Secor, Non-Executive Independent Director Has GW Pharmaceuticals been receiving favorable news coverage? Media headlines about GWP stock have been trending positive on Tuesday, according to Accern Sentiment. The research group ranks the sentiment of news coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. GW Pharmaceuticals earned a coverage optimism score of 0.26 on Accern's scale. They also gave news stories about the biopharmaceutical company an impact score of 46.73 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the near term. How do I buy shares of GW Pharmaceuticals? Shares of GWP and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is GW Pharmaceuticals' stock price today? One share of GWP stock can currently be purchased for approximately GBX 716.60. How can I contact GW Pharmaceuticals? GW Pharmaceuticals' mailing address is Sovereign House, Vision Park, CAMBRIDGE, 00000, United Kingdom. The biopharmaceutical company can be reached via phone at +44-1223-266800. MarketBeat Community Rating for GW Pharmaceuticals (LON GWP)Community Ranking: 2.7 out of 5 ( )Outperform Votes: 70 (Vote Outperform)Underperform Votes: 59 (Vote Underperform)Total Votes: 129MarketBeat's community ratings are surveys of what our community members think about GW Pharmaceuticals and other stocks. Vote "Outperform" if you believe GWP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GWP will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/17/2018 by MarketBeat.com StaffFeatured Article: What does relative strength index mean?